APA

Stechschulte L. A., Ge C., Hinds T. D., Sanchez E. R., Franceschi R. T. & Lecka-Czernik B. (20170526). Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2). : The Journal of biological chemistry.

Chicago

Stechschulte Lance A, Ge Chunxi, Hinds Terry D, Sanchez Edwin R, Franceschi Renny T and Lecka-Czernik Beata. 20170526. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2). : The Journal of biological chemistry.

Harvard

Stechschulte L. A., Ge C., Hinds T. D., Sanchez E. R., Franceschi R. T. and Lecka-Czernik B. (20170526). Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2). : The Journal of biological chemistry.

MLA

Stechschulte Lance A, Ge Chunxi, Hinds Terry D, Sanchez Edwin R, Franceschi Renny T and Lecka-Czernik Beata. Protein Phosphatase PP5 Controls Bone Mass and the Negative Effects of Rosiglitazone on Bone through Reciprocal Regulation of PPARγ (Peroxisome Proliferator-activated Receptor γ) and RUNX2 (Runt-related Transcription Factor 2). : The Journal of biological chemistry. 20170526.